OpenAlex
PricingAboutJobs
Log inGet started
Work

Hypoxia-inducible factor–prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease

HTML PDF

Year: 2021
Type: article
Source: Kidney International Supplements
DOI: 10.1016/j.kisu.2020.12.002
Author: Volker H. Haase
Institutions: Uppsala University, Vanderbilt University, Vanderbilt University Medical Center
Language: English

Topic: Erythropoietin and Anemia Treatment
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: hypoxia-inducible factor prolyl hydroxylase inhibitor, anemia of chronic kidney disease, erythropoiesis, endogenous erythropoietin, hepcidin, iron metabolism, transferrin, total iron binding capacity, intravenous iron supplementation, drug safety
SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Veterans Affairs, AstraZeneca, Vanderbilt University, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Vanderbilt O'Brien Kidney Center, G4252985639
OpenAlex ID: W3137112841
FWCI: 18.38
Cites: 159
Cited by: 210
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security